Stem cell transplantation after alemtuzumab in T-cell prolymphocytic leukaemia results in longer survival than after alemtuzumab alone: a multicentre retrospective study.


Autoria(s): Krishnan Biju; Else Monica; Tjonnfjord Geir E.; Cazin Bruno; Carney Dennis; Carter John; Ketterer Nicolas; Catovsky Daniel; Ethell Mark; Matutes Estella; Dearden Claire E.
Data(s)

2010

Identificador

http://serval.unil.ch/?id=serval:BIB_4D8732332C0F

isbn:1365-2141[electronic], 0007-1048[linking]

pmid:20201944

doi:10.1111/j.1365-2141.2010.08134.x

isiid:000277973400015

Idioma(s)

en

Fonte

British Journal of Haematology, vol. 149, no. 6, pp. 907-910

Palavras-Chave #T-Cell Prolymphocytic Leukaemia; Stem Cell Transplantation; Autograft; Allograft; Alemtuzumab
Tipo

info:eu-repo/semantics/article

article